Product Details
Campral
Acamprosate Calcium333 mg
DR Tablet
DIN/PIN/NPN
02293269
Manufacturer
Mylan Pharmaceuticals ULC
Formulary Listing Date
2018-06-29
Unit Price
0.9601
Amount MOH Pays
0.9601
Coverage Status
Limited Use Product
ODB Formulary Therapeutic Classification
Therapeutic Note
NO
ATC Code
N07BB03
Interchangeable Products
NOLU Clinical Criteria
LU Code | Auth. Period | Clinical Criteria |
---|---|---|
531 | 1 year | For the treatment of alcohol use disorder in patients who: - Meet clinical criteria for alcohol use disorder; and - Express a commitment to abstain from alcohol; and - Have been abstinent from alcohol for at least 3 days prior to starting acamprosate; and - Have confirmed participation in counselling and treatment for alcohol use disorder* * An individualized treatment plan will have one or more of the following components: Counselling and follow-up with the patient's family physician, addiction physician, or psychiatrist; self-help groups such as Alcoholics Anonymous; and outpatient, day, or inpatient psychosocial rehabilitation programs. |